Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/28/15  and contains information from public web pages and contributions from the ZoomInfo community.

A/Prof Kevin Pfleger

Wrong A/Prof Kevin Pfleger?

Chief Scientific Officer, Associa...

Phone: +61 *********  
Email: k***@***.com
Local Address:  NEDLANDS , Western Australia , Australia
Dimerix Bioscience Pty Ltd
Level 2 25 Flinders Lane
Melbourne , Victoria 3000

Company Description: Dimerix aims to offer exciting career opportunities in a young and dynamic team. There are currently no open positions but outstanding individuals with a...   more

Employment History

Board Memberships and Affiliations


  • PhD
    Edinburgh Universities
  • MA
  • Natural Sciences ( Pharmacology
    Cambridge University
  • PhD , Molecular Endocrinology
    University of Edinburgh
  • Natural Sciences ( Pharmacology )
    Cambridge University
92 Total References
Web References
3WED-Connecting medical ..., 28 July 2015 [cached]
3WED-Connecting medical research...Kevin Pfleger (MED) - Copy | Associate Professor Kevin Pfleger Head, Molecular Endocrinology and Pharmacology, Centre for Medical Research, UWA Associate Professor Kevin Pfleger Head, Molecular Endocrinology and Pharmacology, Centre for Medical Research, UWA - UWA Research Week 2015
Associate Professor Kevin Pfleger Head, Molecular Endocrinology and Pharmacology, Centre for Medical Research, UWA
Associate Professor Kevin Pfleger is a National Health and Medical Research Council (NHMRC) RD Wright Biomedical Research Fellow (Level 2), Head of Molecular Endocrinology and Pharmacology at the Perkins and Chief Scientific Advisor of Dimerix Bioscience, a spin-out company from the Perkins and The University of Western Australia. He was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively, and relocated to Western Australia in October 2002. He was a NHMRC Peter Doherty Research Fellow from 2005 to 2008 and an Australian Research Council (ARC) Future Fellow from 2011 to 2014. He was named Western Australian Young Scientist of the Year 2009 and his work featured as one of the NHMRC 10 of the Best Research Projects 2010. In 2011, he was awarded the Australian Museum 3M Eureka Prize for Emerging Leader in Science and in 2012 he won The Endocrine Society Early Investigators Award supported by Amgen and the WA Young Tall Poppy Science Award. Most recently, Associate Professor Pfleger has been honoured with the Endocrine Society of Australia's Mid-Career Research Award for 2014.
Prestigious International Award for Dimerix’s CSO – Dimerix Bioscience, 2 May 2015 [cached]
Dimerix Bioscience's Chief Scientific Officer, Associate Professor Kevin Pfleger, has received a prestigious international award for outstanding accomplishments in Endocrine Research, the study of our hormone systems.
The Early Investigator's Award Supported by Amgen was presented at Endo 2012, the 94th annual meeting of the Endocrine Society, held in Houston, Texas and attended by 7500 scientists from around the world. Associate Professor Pfleger also presented his research at the conference as an invited symposium speaker.
"It was an honour to be invited to present a symposium at this major international meeting, an honour that is usually reserved for those at the top of the field for the last 30 years. To then be recognised with the award as well is simply incredible," he said.
A/Professor Pfleger's laboratory, funded by both National Competitive Grants and Dimerix Bioscience, investigates how hormones work at the molecular and cellular level, by monitoring what happens when hormones specifically interact with proteins on our cells called 'receptors'.
These proteins include G protein-coupled receptors (GPCRs), a particularly important family of receptors that signal through guanine nucleotide-binding proteins, or G proteins for short.
The research by A/Prof Pfleger's team has already made a significant contribution to the understanding of protein interactions and GPCRs. His research could lead to new discoveries that reduce the side effects of pharmaceuticals, particularly through the work being translated by Dimerix.
"We are interested in how receptors interact with other proteins, particularly other types of receptor, to change how they work. We still know remarkably little about how our bodies function at the molecular level, but every year, amazing discoveries are made - it is a very exciting time to be doing medical research".
In addition to being Chief Scientific Officer of Dimerix Bioscience, A/Professor Pfleger is an Australian Research Council Future Fellow and Head of Molecular Endocrinology-GPCRs at WAIMR. He has won numerous Australian science awards, including Western Australian Young Scientist of the Year 2009, NHMRC Ten of the Best Research Projects 2010, and the 2011 Australian Museum 3M Eureka Prize for Emerging Leader in Science.
Dimerix’s patented assay is used to interrogate kinase heteromers. – Dimerix Bioscience, 2 May 2015 [cached]
A/Prof Kevin Pfleger, co-inventor of Dimerix's assay technology, is senior author of a paper entitled 'Profiling Epidermal Growth Factor Receptor and Heregulin Receptor Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology' published 20 May 2013 in PLOS ONE.
Dimerix - Dimerix Team, 19 Jan 2010 [cached]
Kevin Pfleger
Kevin Pfleger BA (Hons), MA, PhD
Chief Scientific Officer
A/Prof Kevin Pfleger is the Chief Investigator of the Dimerix-funded research program being carried out in the Laboratory for Molecular Endocrinology under agreement with WAIMR and the University of Western Australia. Kevin is one of the world's foremost authorities on the use of bioluminescence resonance energy transfer (BRET) technologies to study G-protein coupled receptors. He has published the seminal review and protocol for BRET in Nature Methods and Nature Protocols respectively, as well as publishing a novel derivation of the BRET technology, termed eBRET, that now enables prolonged monitoring of protein-protein interactions in real-time over timescales not previously possible. Kevin is co-inventor of the GPCR-HIT technology assigned to Dimerix from the University of Western Australia.
WAIMR - The WAIMR Team, 23 Nov 2013 [cached]
Kevin Pfleger A/Professor Kevin Pfleger
Head, Laboratory for Molecular Endocrinology and Pharmacology
Other People with the name "Pfleger":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.